DECENTRALIZED TRIAL (DCT) TECHNOLOGY INSIGHTS
-
Not What I Expected From A Vendor Conference
Dan Schell recounts some of his key takeaways after attending the Veeva R&D Quality Summit in Boston in September 2024. Some of the topics discussed include DCTs, eCOA, and the need to simplify tech integration at sites.
-
Can DCTs Be Both Patient Centric And Financially Efficient For Sites?
While DCTs have the potential to provide more convenience and improved access for patients, the anticipated cost savings touted for these trials have yet to materialize fully at the site level. In fact, the opposite has occurred in some instances.
DCT TECHNOLOGY RESOURCES
-
This comprehensive overview illustrates the intersection between prescription digital therapeutics, digital health tools, and decentralized clinical trials in a remote care setting.
-
Discover how forward- thinking life science companies are defining their vision and looking for like-minded partners to execute information technology.
-
With improved access to affordable digital technologies and a regulatory emphasis on diversity in patient recruitment, check out several highlights of the most notable projections in 2023.
-
Decentralized trials and patient choice are key to expanding study reach. Here, we examine how patient access increases with diverse options and AI-powered connections across health systems and sites.
-
This article digs into the specific complexities of long oncology clinical trials and describes relevant solutions to manage the risks regarding patient compliance, clinical project teams, and clinical sites.
-
IQVIA Technologies leaders answer questions from sponsors, sites, CROs, and tech vendors about their aggregation platform that provides single sign-on across sponsors, studies, and systems.
-
The permanent adoption of eCOA is a natural step in the industry-wide effort to create a more patient-centric clinical trial experience. Learn more in the available blog.